Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pharmacological treatments for fatigue associated with palliative care.
Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions.
Concomitant neuromyelitis optica and cytomegalovirus-associated retinitis in an immunocompetent female.
The amyloid state of proteins in human diseases.
Chemokine receptor expression by inflammatory T cells in EAE.
B-61Impact of Sleep Quality, Depression, Daytime Sleepiness, and Fatigue on Cognition in Multiple Sclerosis.
Coenzyme Q10 supplementation and multiple sclerosis.
Neutrophils Mediate Blood-Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases.
Seminal vesicle fluid ameliorates experimental autoimmune encephalomyelitis by increasing FoxP3(+) regulatory T-cell numbers.
How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
Is the Relationship between Cortical and White Matter Pathologic Changes in Multiple Sclerosis Spatially Specific? A Multimodal 7-T and 3-T MR Imaging Study with Surface and Tract-based Analysis.
Translating CESD-20 and PHQ-9 Scores to PROMIS Depression.
Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
Isolated and persistent cognitive dysfunction in a patient with acute disseminated encephalomyelitis.
Comparative Effects of Human Neural Stem Cells and Oligodendrocyte Progenitor Cells on the Neurobehavioral Disorders of Experimental Autoimmune Encephalomyelitis Mice.
Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS.
Can meditation influence quality of life, depression, and disease outcome in multiple sclerosis? Findings from a large international web-based study.
Susceptibility genes are enriched in those of the HSV-1/host interactome in psychiatric and neurological disorders.
Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia.
Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.
Central motor conduction time.
Attributional style and depression in multiple sclerosis: the learned helplessness model.
Pages
« first
‹ previous
…
568
569
570
571
572
573
574
575
576
…
next ›
last »